Boston Scientific is retiring its entire Lotus transcatheter aortic valve replacement (TAVR) platform, citing complexities associated with the product delivery system. There is no safety issue for ...

A locking mechanism problem that led Boston Scientific to “pause” implantations of its Lotus Edge TAVR device has been fixed, the company confirmed today to TCTMD. News of the fix was first published ...

WASHINGTON, DC—The introduction of a depth guard to the Lotus transcatheter aortic valve replacement system (Boston Scientific) appears to have significantly reduced the risk of pacemaker implantation ...

Boston Scientific has retired its entire Lotus Edge heart valve program, effective immediately, leaving a gap in the company’s U.S. transcatheter aortic valve replacement offerings until a new model ...

The RESPOND Post-Market study indicated that less than 5% of the first 250 enrolled (out of a total of 1,000 planned enrollments) patients had mild leakage of a replaced transcatheter aortic valve ...

Global medical device maker Boston Scientific initiated an observational post-market study last week, called the RESPOND Registry, to assess the performance and clinical outcomes of its Lotus ...

PARIS -- The novel Lotus transcatheter aortic valve replacement (TAVR) device reduced paravalvular leak and disabling strokes compared with CoreValve devices but with a high pacemaker rate, according ...

Boston Scientific’s decision to recall its Lotus Edge transcatheter aortic valve replacement product and end the program took us by surprise, and we’re moderately lowering our fair value estimate by ...

LONDON, UK — New results from high-risk patients treated with the Lotus transcatheter aortic valve (Boston Scientific) outside of North America support the positive early results from this so-called ...

Boston Scientific Corp. said it is initiating a global, voluntary recall of all unused inventory of the Lotus Edge aortic valve system, blaming complexities associated with the product delivery system ...

Please provide your email address to receive an email when new articles are posted on . Early European use of the Lotus Edge transcatheter aortic valve replacement system demonstrated good short-term ...

Boston Scientific Corp. said it is initiating a global, voluntary recall of all unused inventory of the Lotus Edge aortic valve system, blaming complexities associated with the product delivery system ...